Arcadia Biosciences (NASDAQ:RKDA) Earns Sell Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a report released on Saturday morning. The firm issued a sell rating on the basic materials company’s stock.

Arcadia Biosciences Stock Performance

Shares of NASDAQ:RKDA opened at $3.29 on Friday. The company’s fifty day moving average is $4.47 and its 200-day moving average is $4.11. Arcadia Biosciences has a 52 week low of $1.85 and a 52 week high of $10.31. The company has a market capitalization of $4.49 million, a PE ratio of -0.77 and a beta of 0.86.

Institutional Trading of Arcadia Biosciences

An institutional investor recently bought a new position in Arcadia Biosciences stock. Geode Capital Management LLC bought a new position in Arcadia Biosciences, Inc. (NASDAQ:RKDA) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 12,297 shares of the basic materials company’s stock, valued at approximately $73,000. Geode Capital Management LLC owned approximately 0.90% of Arcadia Biosciences at the end of the most recent reporting period. Institutional investors own 17.73% of the company’s stock.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.